Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT)

NCT ID: NCT00400868

Last Updated: 2010-02-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare the short- and long-term effectiveness of an individualized, resource-oriented joint protection intervention with the standard, problem-oriented joint protection intervention for patients with rheumatoid arthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Joint Protection (JP)is an important intervention in the management of people with arthritis. Altering working methods (e.g. use of proximal joints, dynamic activities), energy conservation (balance between activity and rest) and using assistive devices should place less strain on joint structures weakened by the disease process. These strategies ought to decrease pain and stress on joints, improve function, and facilitate maintaining social roles.

The effectiveness of JP has been evaluated in a number of studies, all in a group setting. JP has beneficial short-term effects on pain and function in patients with established RA and moderate functional problems. Using assistive devices reduces pain during task performance in comparison to normal methods and altering working methods significantly reduces difficulties in activities of daily living (ADL). However this generally does not result in significant behavioral changes and a long-term impact on reducing pain and maintaining function may only be reached if JP is taught using behavioral education methods. Additionally, adherence of RA patients to different interventions is generally modest, which may well determine the effectiveness of any given intervention, especially in the long-term.

All previous studies were carried out in group settings, however, in Switzerland, standard JP education is provided on a one-to-one basis and an individualized education is assumed to be a promising approach.

This clinical trial aims to test the hypothesis that an individualized, resource-oriented JP education in RA patients leads to a better therapy success in the short and long-term, compared to problem-oriented standard JP education in terms of joint protection behavior. Secondary outcome parameters are self-perception, general and specific self-efficacy and general and health-related quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard joint protection education

psycho-educational joint protection vs. usual care (standard joint protection education)

Group Type ACTIVE_COMPARATOR

psycho-educational Joint protection education

Intervention Type BEHAVIORAL

individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psycho-educational Joint protection education

individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of RA according to ACR Guidelines (1988)
* Actual hand pain on activity or history of wrist and/or metacarpophalangeal(MCP) joint pain and inflammation
* Referred to OT for a Joint Protection intervention program
* Willingness to comply with the randomly assigned treatment and informed consent
* Functional Class: 2 to 4
* German speaking/understanding/reading
* Sufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation

Exclusion Criteria

* Functional class 1 (anticipated self-exclusion, as patients in class 1 will not be referred to JP).
* Severe finger, hand, elbow or shoulder deformities
* Insufficient ability to understand, speak and read the German language
* Insufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zürcher Rheumastifung, Zurich, Switzerland

OTHER

Sponsor Role collaborator

Gertrude and Wolfgang Schrader Dislich Foundation

OTHER

Sponsor Role collaborator

Swiss Ligue Against Rheumatism, Zurich, Switzerland

UNKNOWN

Sponsor Role collaborator

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University Hospital Zurich

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert de Bie, Prof, PhD

Role: STUDY_DIRECTOR

University of Maastricht NL

Karin Niedermann, MPH

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Zurich, CH

Stefan Buchi, MD

Role: STUDY_DIRECTOR

University Hospital of Zurich, CH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital

Bern, , Switzerland

Site Status

Rehabilitation Clinic

Valens, , Switzerland

Site Status

Schulthess Klinik

Zurich, , Switzerland

Site Status

University Hospital

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

niedk_EK444_

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.